Automated Analyzers Market Report 2026

Automated Analyzers Market Overview

• Automated Analyzers market size has reached to $5.39 billion in 2025 • Expected to grow to $7.6 billion in 2030 at a compound annual growth rate (CAGR) of 7% • Growth Driver: Rising Prevalence Of Chronic Diseases Driving Growth In The Automated Analyzers Market • Market Trend: Innovative Advancements In Automated Clinical Chemistry Enhanced Market Growth • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Automated Analyzers Market?

Automated analyzers are laboratory devices designed to perform repetitive analytical tests with minimal human intervention. They enhance efficiency by processing large volumes of samples accurately and rapidly. These systems are commonly used in clinical, chemical, and hematological analyses. The main types of automated analyzers are biochemistry analyzers, immuno-based analyzers, hematology analyzers, and others. Biochemistry analyzers are laboratory instruments used to measure the concentration of various biochemical substances in biological samples for diagnostic and research purposes. They handle sample types including blood, urine, serum, plasma, and others. These analyzers are used in applications such as drug discovery, genomics, proteomics, bioanalysis, clinical diagnostics, and more, and are utilized by end users such as hospitals and clinics, diagnostic laboratories, pharmaceutical and biotechnology companies, and others.

What Is The Automated Analyzers Market Growth Forecast?

The automated analyzers market size is expected to see strong growth in the next few years. It will grow to $7.6 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to advancement in fully automated analyzers, integration with ai and big data analytics, rising demand for rapid diagnostics, expansion of genomics and proteomics research, adoption of point-of-care testing solutions. Major trends in the forecast period include increasing adoption of automated laboratory systems, rising demand for high-throughput sample processing, integration of multi-functional analyzers in labs, growth in clinical diagnostics and research applications, enhanced accuracy and standardization in analytical testing.

Global Automated Analyzers Market Segmentation

1) By Type: Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Other Types 2) By Sample Type: Blood, Urine, Serum, Plasma, Other Sample Types 3) By Application: Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics, Other Applications 4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Other End Users Subsegments: 1) By Biochemistry Analyzers: Clinical Biochemistry Analyzers, Point-of-Care Biochemistry Analyzers, Integrated Biochemistry Systems 2) By Immuno-Based Analyzers: Immunoassay Analyzers, Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Chemiluminescent Immunoassay (CLIA) Analyzers 3) By Hematology Analyzers: Automated Hematology Analyzers, Flow Cytometry-Based Hematology Analyzers, Complete Blood Count (CBC) Analyzers 4) By Other Types: Molecular Analyzers, Urinalysis Analyzers, Coagulation Analyzers

What Is The Driver Of The Automated Analyzers Market?

The rising prevalence of chronic diseases is expected to propel the growth of the automated analyzers market going forward. The prevalence of chronic diseases is rising due to aging populations, unhealthy lifestyles, and increased urbanization globally. Automated analyzers are used in chronic disease management for efficient and accurate diagnostic testing, enabling early detection, monitoring, and treatment of conditions like diabetes, cardiovascular diseases, and kidney disorders. For instance, in June 2023, according to the report published by Kidney Research UK, a UK-based non-profit organization, approximately 7.2 million people in the UK are living with chronic kidney disease, representing over 10% of the population. Of these, 3.25 million are in the advanced stages of the disease, while an additional 3.9 million are in the early stages. By 2033, the number of individuals affected by chronic kidney disease is projected to rise to 7.61 million. Therefore, the rising prevalence of chronic diseases is driving the growth of the automated analyzers industry.

Key Players In The Global Automated Analyzers Market

Major companies operating in the automated analyzers market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Honeywell International, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Tosoh Corporation, Agilent Technologies Inc., Grifols S.A., Xylem Inc., Hitachi High-Tech Corporation, Mindray, PerkinElmer Inc, bioMérieux SA, Sysmex Corporation, Bruker Corporation, Horiba Medical, Randox Laboratories Ltd., Nova Biomedical Corporation, Trinity Biotech Plc

Global Automated Analyzers Market Trends and Insights

Major companies operating in the automated analyzers market are focusing on developing innovative solutions such as automated clinical chemistry analyzers to enhance efficiency, accuracy, and throughput in diagnostic laboratories. Automated clinical chemistry analyzers refer to advanced instruments used in laboratories to perform a wide range of chemical tests on blood and other bodily fluids with minimal human intervention, enhancing efficiency and accuracy in diagnostic testing. For instance, in January 2024, Beckman Coulter, a US-based manufacturing company, launched the DxC 500 AU Chemistry Analyzer, which represents a cutting-edge advancement in automated clinical chemistry. Boasting over 120 high-quality assays, this analyzer is engineered to significantly enhance the capabilities of satellite and independent community hospital labs. It integrates sophisticated automation, streamlined workflows, and standardized reagents to boost testing efficiency and aid in clinical decision-making. By serving as a vital complement to central hub laboratories within healthcare systems that utilize hub-and-spoke models, the DxC 500 AU enhances overall efficiency and expands access to essential testing services.

What Are Latest Mergers And Acquisitions In The Automated Analyzers Market?

In April 2024, Valmet, a Finland-based technology company, acquired the process gas chromatography business from Siemens Healthineers AG for $113.05 million. The acquisition aligns with Valmet’s strategy to boost its automation segment and process automation capabilities, especially in gas chromatograph and process analyzer systems. The acquired business will become part of Valmet’s automation systems division under a new unit, analyzer products, and integration, strengthening its position in this field. Siemens Healthineers AG is a Germany-based engineering and manufacturing company that specializes in automated analyzers.

Regional Outlook

North America was the largest region in the automated analyzers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Automated Analyzers Market?

The automated analyzers market consists of sales of biochemistry analyzers, hematology analyzers, immunoassay analyzers, blood gas analyzers, and molecular analyzers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.